Janux Therapeutics
Janux Therapeutics is seeking an Executive Director, Head of Bioinformatics to lead and develop a bioinformatics and computational biology function supporting discovery, translational, and clinical development programs in oncology and immunology. The role involves defining strategic vision, owning multi-omic strategies, and serving as a scientific partner across various research and clinical teams.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
11% above the average for this role
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
Computational Biology & Bioinformatics Scientist
ZIFO GmbH
Scientist/Senior Scientist, Computational Biology
Volastra Therapeutics
Senior Director of Bioinformatics
Summit Therapeutics,
Postdoctoral Research Fellow
The University of British Columbia
Director of Oncology Genomics & Data Science
GSK plc
Scientist, Oncology Bioinformatics
Moderna